Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]

PARP inhibitory velaparib trialled in BRCA1/2 breast cancer

Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA

PARP inhibitory velaparib trialled in BRCA1/2 breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )

Matched mutations in the progression of metastatic breast cancer

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA

Matched mutations in the progression of metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )

Comparison between standard and reduced volume radiotherapy in bladder...

Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt

Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients ( Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt )

PD-1 therapy with eribulin for triple negative MBC

Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA

PD-1 therapy with eribulin for triple negative MBC ( Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA )

Breast cancer mortality declining globally

Dr Cécile Pizot - International Prevention Research Institute, Lyon, France

Breast cancer mortality declining globally ( Dr Cécile Pizot - International Prevention Research Institute, Lyon, France )

Everolimus extends PFS for HR positive, HER2 negative breast cancer

Dr Noah Kornblum - Montefiore Medical Center, New York, USA

Everolimus extends PFS for HR positive, HER2 negative breast cancer ( Dr Noah Kornblum - Montefiore Medical Center, New York, USA )

TEAM IIb trial results: Adjuvant ibandronate in early breast cancer

Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands

TEAM IIb trial results: Adjuvant ibandronate in early breast cancer ( Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands )

Neoadjuvant abemaciclib for HR positive, HER negative breast cancer

Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA

Neoadjuvant abemaciclib for HR positive, HER negative breast cancer ( Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA )

TCHP with/out oestrogen for HR/HER positive breast cancer

Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA

TCHP with/out oestrogen for HR/HER positive breast cancer ( Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA )

Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in...

Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA

Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in metastatic breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )

Extended adjuvant endrocine therapy with letrozole after aromatase inhibition

Dr Terry Mamounas - UF Health Center, Orlando, USA

Extended adjuvant endrocine therapy with letrozole after aromatase inhibition ( Dr Terry Mamounas - UF Health Center, Orlando, USA )

Whole exome and transcriptome sequencing of resistant ER positive metastatic...

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA

Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )

More from ecancer